Abstract
Five healthy volunteers and 31 patients with various degrees of renal impairment received a 10-mg/kg intravenous dose of amdinocillin by infusion over 15 min to establish the disposition profile of the drug in plasma and urine. Both clearance from plasma and elimination rate constant showed a linear relationship with creatinine clearance. It was noted that in subjects with creatinine clearances of greater than 50 ml/min, the elimination half-life remained relatively constant; however, as the creatinine clearance decreased from 50 to 5 ml/min, there was a progressive rise in the elimination half-life. Despite the removal of the drug by hemodialysis (32 to 72% of the dose), concentrations of amdinocillin in plasma remained in the therapeutic range. In patients undergoing peritoneal dialysis, less than 4.0% of the infused dose was removed by dialysis during the hourly exchanges over a 14- to 18-h period. Although the clearance from plasma and the half-life of amdinocillin were altered up to fourfold in patients with creatinine clearances of less than 15 ml/min, the amdinocillin dosage per se may not need to be reduced for these patients if the frequency of dosing is reduced from six to three or four times daily. This is based on drug accumulation estimates of 56% from a regimen of 10 mg/kg every 8 h in these patients as compared with less than 10% from a regimen of 10 mg/kg every 4 h in subjects with normal renal function. In addition, supplemental doses may not be necessary during or at the end of hemodialysis for patients undergoing hemodialysis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bailey K., Cruickshank J. G., Bisson P. G., Radford B. L. Mecillinam in patients on haemodialysis. Br J Clin Pharmacol. 1980 Aug;10(2):177–180. doi: 10.1111/j.1365-2125.1980.tb01741.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baltimore R. S., Klein J. O., Wilcox C., Finland M. Synergy of mecillinam (FL1060) with penicillins and cephalosporins against Proteus and Klebsiella, with observations on combinations with other antibiotics and against other bacterial species. Antimicrob Agents Chemother. 1976 Apr;9(4):701–705. doi: 10.1128/aac.9.4.701. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barriere S. L., Gambertoglio J. G., Lin E. T., Conte J. E., Jr Multiple-dose pharmacokinetics of amdinocillin in healthy volunteers. Antimicrob Agents Chemother. 1982 Jan;21(1):54–57. doi: 10.1128/aac.21.1.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gambertoglio J. G., Barriere S. L., Lin E. T., Conte J. E., Jr Pharmacokinetics of mecillinam in health subjects. Antimicrob Agents Chemother. 1980 Dec;18(6):952–956. doi: 10.1128/aac.18.6.952. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lund F., Tybring L. 6 -amidinopenicillanic acids--a new group of antibiotics. Nat New Biol. 1972 Apr 5;236(66):135–137. doi: 10.1038/newbio236135a0. [DOI] [PubMed] [Google Scholar]
- Meyers B. R., Jacobson J., Masci J., Srulevitch E., Hirschman S. Z. Pharmacokinetics of amdinocillin in healthy adults. Antimicrob Agents Chemother. 1983 Jun;23(6):827–830. doi: 10.1128/aac.23.6.827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mitchard M., Andrews J., Kendall M. J., Wise R. Mecillinam serum levels following intravenous injection: a comparison with pivmecillinam. J Antimicrob Chemother. 1977 Jul;3 (Suppl B):83–88. doi: 10.1093/jac/3.suppl_b.83. [DOI] [PubMed] [Google Scholar]
- Neu H. C. Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria. Antimicrob Agents Chemother. 1976 May;9(5):793–799. doi: 10.1128/aac.9.5.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roholt K. Pharmacokinetic studies with mecillinam and pivmecillinam. J Antimicrob Chemother. 1977 Jul;3 (Suppl B):71–81. doi: 10.1093/jac/3.suppl_b.71. [DOI] [PubMed] [Google Scholar]
- Svarva P. L., Wessel-Aas T. Serum levels of mecillinam in patients with severely impaired renal function. Scand J Infect Dis. 1980;12(4):303–305. doi: 10.3109/inf.1980.12.issue-4.11. [DOI] [PubMed] [Google Scholar]
- Tybring L. Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: in vitro evaluation. Antimicrob Agents Chemother. 1975 Sep;8(3):266–270. doi: 10.1128/aac.8.3.266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tybring L., Melchior N. H. Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: bactericidal action and synergy in vitro. Antimicrob Agents Chemother. 1975 Sep;8(3):271–276. doi: 10.1128/aac.8.3.271. [DOI] [PMC free article] [PubMed] [Google Scholar]